Page last updated: 2024-10-24

bupivacaine and Lung Injury, Acute

bupivacaine has been researched along with Lung Injury, Acute in 2 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, D1
Li, K1
Yang, M1
Zhang, H1
Miao, Y1
Schley, MT1
Casutt, M1
Haberthür, C1
Dusch, M1
Rukwied, R1
Schmelz, M1
Schmeck, J1
Schüpfer, GK1
Konrad, CJ1

Other Studies

2 other studies available for bupivacaine and Lung Injury, Acute

ArticleYear
Levobupivacaine attenuates lipopolysaccharide-induced acute lung injury.
    Fundamental & clinical pharmacology, 2016, Volume: 30, Issue:4

    Topics: A549 Cells; Acute Lung Injury; Anesthetics, Local; Animals; Anti-Inflammatory Agents; Bupivacaine; D

2016
Long-acting local anesthetics attenuate FMLP-induced acute lung injury in rats.
    Anesthesia and analgesia, 2009, Volume: 109, Issue:3

    Topics: Acute Lung Injury; Amides; Anesthesia, Local; Animals; Anti-Inflammatory Agents; Bupivacaine; Endoth

2009